mrd2stop: can multimodal mrd negativity guide discontinuation of maintenance treatment in myeloma?
Published 1 year ago • 810 plays • Length 12:09Download video MP4
Download video MP3
Similar videos
-
2:05
using mrd negativity to measure depth of response & to discontinue treatment in multiple myeloma
-
1:28
mrd negativity in myeloma patients undergoing maintenance therapy
-
1:02:07
is mrd negativity the goal of myeloma treatment?
-
3:18
what does it mean when a myeloma patient is mrd negative?
-
1:27
maintenance therapy and mrd in myeloma
-
0:55
sustained mrd negativity in multiple myeloma
-
2:27
mrd-guided therapy in multiple myeloma
-
4:10
how does minimal residual disease (mrd) testing affect treatment decisions?
-
3:43
mrd-guided treatment cessation in multiple myeloma
-
2:31
evaluating the safety of maintenance therapy cessation in mrd negative myeloma patients
-
4:53
clinical implications of loss of minimal residual disease (mrd) negativity in multiple myeloma
-
1:59
mrd negativity as predictors of early relapse in transplant-eligible multiple myeloma patients
-
1:01:02
is mrd negativity the end goal? understanding when/why it's important
-
35:56
international myeloma workshop 2021 | daily update, part 1 | newly diagnosed mrd
-
1:38
using mrd to guide therapy in multiple myeloma
-
1:20
how can someone be mrd negative and not in a complete response?
-
0:47
sustained mrd for treatment guidance in myeloma
-
1:36
the importance of mrd as a prognostic tool in multiple myeloma
-
4:01
if a myeloma patient has mrd-negative status, does that mean that patient is cured?